Search Results - "Dapretto, Elisa"

Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study by Colucci, Giuseppe, Labianca, Roberto, Di Costanzo, Francesco, Gebbia, Vittorio, Cartenì, Giacomo, Massidda, Bruno, Dapretto, Elisa, Manzione, Luigi, Piazza, Elena, Sannicolò, Mirella, Ciaparrone, Marco, Cavanna, Luigi, Giuliani, Francesco, Maiello, Evaristo, Testa, Antonio, Pederzoli, Paolo, Falconi, Massimo, Gallo, Ciro, Di Maio, Massimo, Perrone, Francesco

“…Single-agent gemcitabine became standard first-line treatment for advanced pancreatic cancer after demonstration of superiority compared with fluorouracil. The…”
Get full text

Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial by Cascinu, Stefano, Prof, Berardi, Rossana, MD, Labianca, Roberto, MD, Siena, Salvatore, MD, Falcone, Alfredo, Prof, Aitini, Enrico, MD, Barni, Sandro, MD, Di Costanzo, Francesco, MD, Dapretto, Elisa, MD, Tonini, Giuseppe, Prof, Pierantoni, Chiara, MD, Artale, Salvatore, MD, Rota, Silvia, MS, Floriani, Irene, PhD, Scartozzi, Mario, MD, Zaniboni, Alberto, MD

“…Summary Background Preclinical data have suggested a synergistic effect of cetuximab combined with gemcitabine and cisplatin and clinical data have shown a…”
Get full text